Acorah Software Products - Accounts Production 19.2.450 false true 31 August 2024 31 August 2023 false true No description of principal activity 1 September 2024 31 August 2025 31 August 2025 15106751 Mr M M Razaq Ms S A Shaikh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15106751 2024-08-31 15106751 2025-08-31 15106751 2024-09-01 2025-08-31 15106751 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 15106751 frs-bus:FilletedAccounts 2024-09-01 2025-08-31 15106751 frs-bus:Micro-entities 2024-09-01 2025-08-31 15106751 frs-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 15106751 frs-bus:Director1 2024-09-01 2025-08-31 15106751 frs-bus:Director2 2024-09-01 2025-08-31 15106751 2023-08-30 15106751 2024-08-31 15106751 2023-08-31 2024-08-31
Registered number: 15106751
Synergy Health Group Ltd
Unaudited Financial Statements
For The Year Ended 31 August 2025
JABR
Chartered Certified Accountants
376 Walsall Road
Birmingham
B42 2LX
Balance Sheet
Registered number: 15106751
2025 2024
as restated
£ £
Current assets 40 100
NET CURRENT ASSETS 40 100
TOTAL ASSETS LESS CURRENT LIABILITIES 40 100
NET ASSETS 40 100
CAPITAL AND RESERVES 40 100

Notes

1. General Information
Synergy Health Group Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15106751 . The registered office is 29 Sandy Lane, Newcastle, England, ST5 0LX.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr M M Razaq
Director
22 May 2026